Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis

NCT03707587 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03707587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
December 19, 2018
Completion date
July 6, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus, laryngeal papilloma, recurrent, recurrent respiratory papillomatosis, respiratory papillomatosis